Fabrice Chouraqui
Vermogen: 196 327 $ op 31-10-2026
Vermogen: 196 327 $ op 31-10-2026
Fabrice Chouraqui is currently an Independent Member of the Governors Board at Orano Med Manufacturing SAS. Former roles include Chief Executive Officer & Director at Cellarity Inc., Chief Executive Officer & Executive Director at Pharming Group NV from 2025 to 2026, and President at Novartis Pharmaceuticals Corp.
from 2016 to 2019.
Education includes an MBA from INSEAD and graduate and doctorate degrees from Universite Paris Cite.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARMING GROUP NV 0,02% | 31-03-2026 | 161.425 ( 0,02% ) | 196 327 $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMING GROUP N.V. | Algemeen Directeur | 29-09-2026 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | President | 01-01-2019 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Algemeen Directeur | 12-05-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau